Lawrence Piccioni, MD
Orthopaedic Surgery · Dover, DENPI 1487651865
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Arthrex at 47.9% of the total. Reporting peaked in 2023 at $2,607 and has fallen 95.0% since, to $130 in 2025.
Across 95 payments — averaging $77.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Supreme Orthopedic Systems, LLC$3K
- Stryker$210
- Medtronic$178
- Abbott$119
- Ferring Pharmaceuticals Inc.$95
- plus $548 from 20 others
What the payments were for
- Travel & lodging$2,40432%
- Food & beverage$1,75224%
- Education$3,25244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $3,552 |
| Supreme Orthopedic Systems, LLC | 12 | $2,707 |
| Stryker | 10 | $210 |
| Medtronic(2 entities) | 8 | $178 |
| Abbott | 7 | $119 |
| Ferring Pharmaceuticals Inc. | 5 | $95 |
| Baxter Healthcare | 2 | $75 |
| Endo Pharmaceuticals Inc. | 3 | $64 |
| Heron Therapeutics, Inc. | 2 | $43 |
| Electronic Waveform Lab, Inc. | 2 | $42 |
| Pacira Pharmaceuticals Incorporated | 3 | $38 |
| Smith+Nephew | 1 | $32 |
| Zimmer Biomet | 2 | $28 |
| KCI USA, Inc. | 1 | $26 |
| Vertex | 1 | $25 |
| Lifenet Health | 1 | $23 |
| Eclipse Technology Solutions Inc. | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Si-bone, Inc. | 1 | $17 |
| Endo USA, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $14 |
| Synergy Orthopedics, LLC | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $10 |
| Orthofix Medical, Inc. | 1 | $8 |
How this compares
$7,408 in reported general payments places this provider in the 55th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 36 | $711 |
| Meloxicam | 45 | $423 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $282 |
| Prednisone | 32 | $138 |
| Clindamycin Hcl | 44 | $96 |
| Tramadol Hcl | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Dover
- Andrew GamboneDover$16K
- Darshdeep SinghDover$15K
- Marek DenisiukDover$8K
- Stephen ManifoldDover$2K
- Trinity PilkingtonDover$2K
- John BurgerDover$1K
- Steven ToozeDover$1K
- Suken ShahWilmington$2.1M
- Jeremie AxeNewark$179K
- Andrew CurleySeaford$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.